Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
CellSight Technologies, Inc.
A positron emission tomography (PET) imaging tracer will be intravenously injected into healthy human volunteers who provide informed consent. Following injection of this tracer each volunteer will have four whole-body PET scans inside a PET scanner to obtain images of tracer biodistribution at four different time points. This will allow studying the kinetics of the tracer as well analysis of tracer dosimetry. Safety of the tracer will also be analyzed in each volunteer.
Age
18–any
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Healthy human subjects without history of chronic disease or at present an acute disease will be included.
Ability to abide by the study conditions is also a requirement for inclusion.
You may not be if
Individuals under the age of 18 years and pregnant women will be excluded from the \[18F\]F-AraG imaging studies.
Women who are breast-feeding will be excluded from the study.
Individuals unable to provide informed consent will be excluded.
